A randomized cross-over study to evaluate the safety and pharmacokinetics of 141W94, zidovudine and lamivudine alone and in combination after single-dose administration in HIV-infected subjects., Trial ID PROA1003

A randomized cross-over study to evaluate the safety and pharmacokinetics of 141W94, zidovudine and lamivudine alone and in combination after single-dose administration in HIV-infected subjects., Trial ID PROA1003 | GSK